Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Netmore Group AB enter partnership with Warth & Klein Grant Thornton to develop 5G in Germany

Netmore´s German Netmore GmbH and Warth & Klein Grant Thornton have agreed a partnership to support companies in the implementation and roll out of private 5G networks in Germany. Warth & Klein Grant Thornton is one of the leading audit and consulting companys in Germany and will be a strategically important partner for Netmore`s 5G development in the German market.With regard to digitisation and automation, both companies see a high potential for 5G use in the economy. In particular, the expansion of self-hosted 5G networks (campus networks) is seen by both companies as a cost-effective

ZUTEC SIGNS CONTRACT FOR INFRASTRUCTURE PROJECT IN U.A.E.

Zutec Holding AB (publ) (“Zutec") today announced that it has signed a contract for an infrastructure project in the U.A.E.  The 33 months contract is worth ca €0.35 million (SEK3.8 million) and is entirely for cloud-based software licensing.“This infrastructure project is large and complex and we are pleased to see that both our Inspection and Handover modules are being used on this project. Our commitment to the region is steadfast and we look forwards to partnering with other customers in the region ”, says Gustave Geisendorf, CEO of Zutec. For more information, please contact:

Saldo Finance continued to grow with net sales up by 20 % and operating profit by 6 % in 2019

For Saldo Finance Plc, a leading provider of automated credit solutions, 2019 was a year of scalable growth. The company diversified its business while continuing to grow net sales and improving profitability2019 was the Saldo Finance's best year ever in terms of net sales and profitability. Net sales increased during 2019 by 19.8 % to EUR 53.9 million (2018: EUR 44.9 million). Profitability remained at an excellent level as operating profit (EBIT) increased by 6.20 % compared to the previous year and was EUR 27.4 (25.8) million. The operating profit margin was 50.8 % (57.3 %). The company'

Outotec launches new open-ended discharge grinding mill solution for high-throughput circuits

With ore grades declining and cost pressures rising, high-throughput circuits based on very large grinding mills are becoming an increasingly attractive option in mineral concentration applications. The Outotec® Open Ended Discharge Grinding Mill (OED Mill) enables innovative and efficient high-capacity circuit designs through the removal of pulp lifters from the discharge arrangement, facilitating reductions in both CAPEX and OPEX. Instead of using pulp lifters, the OED Mill discharges material directly through the grates, solving the throughput bottleneck problem often associated with

Bambuser enters into agreement with Indiska for Live Video Shopping

Bambuser AB has entered into an agreement with Indiska Magasinet Aktiebolag. The agreement runs for six months and relates to a limited version of Live Video Shopping for retail. The company estimates that the revenue will be lower in relation to previously signed agreements for a full version.   On May 13, 2020, Bambuser announced that the company will begin offering a few selected companies different packages to lower the threshold for SMEs to enter into Live Video Shopping contracts and to evaluate a varied pricing strategy that caters to future potential customers in different

BioStock: New patent notice rounds off an eventful six months for Follicum

During the first half of 2020, Follicum has started, paused and resumed a phase II study with its primary candidate FOL-005. An international patent application has been filed regarding its newly developed topical formulation as a carrier of peptide drugs. New collaborations have been entered in regard to the company’s diabetes project and several patents have been obtained, most recently from the US Patent Office. As of now, the company has a solid IP protection for its peptides developed with the aim of treating diabetes and its complications, in both Europe and the United States, and the

2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program

2cureX AB (“2cureX”) today announces that the company has received a third payment of EUR 596,886 from the EU’s Horizon 2020 SME Program . The grant is given to finalize the clinical validation of the company’s IndiTreat® product and to initiate market launch.As previously communicated, 2cureX has in February 2018 started a project funded with a EUR 3 million grant from the EU’s Horizon 2020 SME Program. Partners in the project are cancer hospitals in Denmark, Germany, the United Kingdom and Sweden as well as the patient organization

ABS Leads as Founding Member of the Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping

Leading Industry Companies Team to Deliver IMO Decarbonization Ambitions(COPENHAGEN) ABS is a founding member of the Mærsk Mc-Kinney Møller Center for Zero Carbon Shipping (MCZCS), a new research center designed to support shipping’s decarbonization ambitions, which launches today.The founding partners behind the MCZCS are ABS, A.P. Moller - Maersk, Cargill, MAN Energy Solutions, Mitsubishi Heavy Industries, NYK Line and Siemens.The center, which will be based in Copenhagen, Denmark, is made possible by a start-up donation of DKK 400m by the A.P. Moller Foundation to contribute to

Alfa Laval signs agreement with leading engine developer

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – continues to expand its offering to marine customers, catering to their needs no matter which fuel they use to propel their vessels. The new addition Alfa Laval CEC-S solution, developed in cooperation with the global Swiss engine developer WinGD, is targeting ships that run on gas and it will improve the engine efficiency on ships that run on gas.The new Alfa Laval CEC-S system (cascade exhaust gas cooling system) will be incorporated into WinGD’s gas engines where it will be used for cooling and

Evolution extends Rush Street relationship with First Person games for Colombian market

Evolution Gaming, leading provider of Live Casino solutions, has announced that it is extending its relationship with Rush Street Interactive with the launch of six Evolution First Person games for the Colombian online gaming market on RushBet.co.The six First Person titles — First Person Roulette, Lightning Roulette, Blackjack, Dream Catcher, Baccarat and Mega Ball — are all RNG versions of Evolution Live Casino games that are well established and very popular across Europe and North America. All of the First Person variants will be added to RushBet.co´s iGaming platform for Colombia

Obducat receives order valued at 3.1 million SEK from a well renowned R&D institute in Germany

OBDUCAT AB (publ) subsidiary Obducat Europe GmbH, a leading supplier of system solutions for lithography processing, has received an order from a well renowned R&D institute in Germany, for the supply of five bench mounted lithography processing modules. The order value amounts to approx. 3.1 million SEK.The processing modules will be integrated into a larger processing unit for use in applied research in the field of photonics and innovative optical systems to control light. No further information can be given now due to confidentiality requirements. The processing modules are planned

The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer.  Orphan Medicinal Product designation provides certain regulatory and financial incentives for companies to develop and market therapies that treat a life-threatening or chronically debilitating condition affecting no more than five in

Press conference, June 30: Polygiene ViralOff – from launch to category leader in 3 months

We would like to invite you to our orientation on ViralOff®, an opportunity to give you essential information and updates. Polygiene CMO and PhD Mats Georgson will present the big picture, several new developments and launches. In addition, we will also look at the intricacies and importance of global testing parameters surrounding viruses and of course, Covid-19 in particular. The key concept here is pandemic sustainability – taking care of both viruses as well as the planet means being tough on the former but nice to the latter. We look forward to having you there! Start

Moberg Pharma meets primary endpoint in the European Phase 3 study

STOCKHOLM, June 25[th], 2020, Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) met the primary endpoint in the European Phase 3 study including 452 onychomycosis patients, showing non-inferiority versus topical ciclopirox. Mycological cure was achieved in 84 percent of patients, which is unprecedented for a topical treatment and even higher than reported for oral treatments. The pattern is consistent with the results from the North American Phase 3 study, with low complete cure rates despite the high mycological cure rates. Moberg Pharma will discuss next steps with

Sedana Medical expands in Eastern Europe – signs distribution agreements

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that it has signed agreements with distributors in Bulgaria, Cyprus, Greece, Slovakia and the Czech Republic. The agreements are part of the preparations ahead of the registration of the drug candidate IsoConDa, which is expected next year.“We highly appreciate the great interest there is in launching and selling AnaConDa in the markets we do not cover ourselves. Through this expansion of our distributor network, we are strengthening the position ahead of the upcoming market launch of our therapy,” said Christer Ahlberg, CEO of

Aker ASA: Aker BioMarine AS – Successful completion of private placement

NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR ANY JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF LOCAL SECURITIES LAWS OR REGULATIONS. Reference is made to the announcement published on 19 June 2020, regarding the private placement of new shares (the “Private Placement”) in Aker BioMarine AS (the "Company"). The application period for the Private Placement expired at 16:30 CEST on 24 June 2020 after the application period was shortened as announced on 23 June 2020.

RepRisk partners with Battlefin to offer ESG datasets for the alternative data community

The world’s largest dataset on ESG and business conduct risk is now available as part of BattleFin’s alternative data suite of solutionsZurich, Switzerland, and London, UK – June 25, 2020 – RepRisk, a pioneer and leader in ESG data science combining machine learning and human intelligence, has formed a strategic partnership with alternative data platform and marketplace BattleFin that will significantly expand alternative data buyer access to ESG risk data.   RepRisk’s daily-updated dataset on nearly 150,000 companies linked to ESG and business conduct risks will be available through

Filo Mining Outlines Potential to Significantly Expand the Current Filo del Sol Resource

VANCOUVER, JUNE 25, 2020 /CNW/: Filo Mining Corp. (TSXV, Nasdaq First North Growth Market: FIL) ("Filo Mining”, or the “Company”) is pleased to provide a summary of the results of the recently completed 2019/2020 field program at the Filo del Sol project, and to discuss the implications of these results for the ultimate size of this impressive mineral system. Commenting on the recent results, President and CEO Jamie Beck stated, “Our latest drill program has transformed our understanding of the size and scale of the Filo system. Standout results include two of the best copper-gold

Lundin Gold Announces Voting Results from Annual Meeting

June 24, 2020 (Vancouver, Canada) /CNW/ Lundin Gold Inc. ("Lundin Gold" or the "Company") (TSX: LUG, Nasdaq Stockholm: LUG) is pleased to report the voting results from the Company’s 2020 Annual General Meeting of Shareholders (“Annual Meeting”), which was held earlier today in Vancouver, British Columbia.  Election of Directors The ten nominees listed in the management proxy circular for the Annual Meeting were elected as directors of the Company. The detailed results of the vote for the election of directors held at the Annual Meeting are set out below. +--------------------+-----

Leading Edge Materials Reports Quarterly Results to April 30, 2020

Vancouver, BC, June 24, 2020 /CNW/ – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces second quarter results for the period ending April 30, 2020. All references to dollar amounts in this release are in Canadian dollars.  Three Months Ended April 30, 2020 Compared to Three Months Ended January 31, 2020During the three months ended April 30, 2020 (“Q2”) the Company reported a net loss of $317,422 compared to a net loss of $407,304 for the three months ended January 31, 2020 (“Q1”), a decrease in

Citigroup notifies that stabilization measures have been undertaken in Calliditas Therapeutics' ADSs traded on The Nasdaq Global Select Market

Citigroup Global Markets Inc. ("Citigroup"), in its capacity as Joint Global Coordinator, notifies that stabilization measures have been undertaken in Calliditas Therapeutics AB's (”Calliditas” or the “Company”) American Depositary Shares ("ADSs"), traded on The Nasdaq Global Select Market.As announced by the Company in connection with the initial public offering on The Nasdaq Global Select Market, by way of a capital increase of new common shares in the form of ADSs, each representing two (2) underlying new common shares of Calliditas, (the "U.S. Offering"), and a concurrent private

Observe Medical ASA – Investor presentations in connection with the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Observe Medical ASA is conducting a range of investor meetings in connection with the ongoing rights issue. Presentation material for the meetings follows enclosed. Investors are welcome to join group

Photocure ASA – Private placement successfully placed

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, Norway, 24 June 2020: Reference is made to the stock exchange notice earlier today where Photocure ASA ("Photocure" or the "Company") announced

Chairman taken into custody

Earlier today, Brighter announced that the company's chairman today, on June 24, has been picked up by the Economic Crime Authority for questioning. The prosecutor in charge, Jonas Myrdal, has confirmed that the person is held under custody and that a preliminary investigation has been initiated. At the same time, we currently have very limited information on the matter. Now we have to wait and see what the investigation shows. For further information, please contact: Henrik Norström, CEO+46 733 40 30 45ir@brighter.se Certified AdviserBrighter’s Certified Adviser is

There are no items matching the current filter
There are no more items matching the current filter
Back to top